Schizophrenia Clinical Trial

KRK Medical Research is seeking volunteers to participate in ongoing medical studies to evaluate the effectiveness of investigational medications for the treatment of Schizophrenia. We currently have several ongoing studies which you may qualify.

These are nationwide studies sponsored by Amgen, Inc.

To qualify:
Male or female between the ages of 18 and 60. Diagnosis of schizophrenia and taking medication for it for at least 8 weeks.

Participation Duration:
The duration of study will be 20 weeks with a total of 14 visits.

Subject Compensation: Up to $700.

Principal Investigator: Andrew Klymiuk, M.D.

All study related medical procedures, physical examinations, physician visits, laboratory tests, and investigational medication are at no charge.  No health insurance is needed.

If you would like to receive more information about the Schizophrenia Clinical Trial, please Click Here . One of our Nurse Research Coordinators will get back to you within 24 hours.

Click here for more information

You may also call one of our patient specialists at 972-907-1333.

Be assured that all information is kept strictly confidential per HIPPA regulations, FDA laws, and the American Medical Association ethical guidelines.